Longevity is a
systems problem.
Living longer isn't the interesting goal — living well for longer is. That's healthspan, and the research on how to protect it keeps coming back to a small set of biological processes that quietly break down with age, reinforce each other, and drive almost everything people call "aging." This is a plain-English, evidence-graded guide to those processes and what actually helps.
What longevity actually means
Not just "years lived" — years lived well.
Lifespan is how long you live. Healthspan is how long you live without significant disease or disability — the years you're actually strong, sharp, and independent. Modern medicine has been much better at extending the first than the second: people are living longer, but often with more years spent managing chronic disease, not fewer.
Longevity science is the attempt to close that gap — to compress the period of decline toward the very end of life instead of stretching it across decades. The research increasingly points to aging itself as a modifiable process, not a fixed countdown, driven by a handful of interacting biological failures rather than one single cause.
Factors affecting longevity
Aging researchers increasingly frame decline through the hallmarks of aging — twelve interacting biological processes identified by López-Otín and colleagues (2023). These three sit at the center of that web, each one both a cause and a consequence of the others.
Insulin Resistance
When cells stop responding properly to insulin, blood sugar control degrades and the metabolic damage compounds for decades before symptoms show up.
Explore →Chronic Inflammation
Low-grade, persistent inflammation — "inflammaging" — quietly drives cardiovascular disease, cognitive decline, and nearly every other hallmark of aging.
Explore →Mitochondrial Health
Nearly every cellular repair process runs on energy your mitochondria produce. When they decline, the budget for maintaining everything else shrinks with them.
Explore →Latest longevity videos
Hand-picked YouTube episodes on mitochondrial health, metabolic health, and inflammation.
Inflammation: its impact on aging and disease risk, and how to identify and prevent it
Inflammaging: How Chronic Inflammation Drives Biological Age
Improve Energy & Longevity by Optimizing Mitochondria
Dr. Ben Bikman: How To Reverse Insulin Resistance Through Diet, Exercise & Sleep
Insulin resistance masterclass: the full body impact of metabolic dysfunction
Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects
Essentials: Micronutrients for Health & Longevity | Dr. Rhonda Patrick
→More videos & articlesLongevity on podcasts
Hand-picked episodes on mitochondrial health, metabolic health, and inflammation from reputable health podcasts.
Inflammation: its impact on aging and disease risk, and how to identify and prevent it
Attia separates acute from chronic inflammation, works through which inflammatory markers are actually worth measuring versus which are noise, and what genuinely lowers chronic inflammatory burden. A practical counterpart to the mechanistic literature.
ListenLongevity in the literature
Studies, reviews, and explainers worth reading — evidence-graded where it applies.
Mitochondrial calcium influx-driven bioenergetics selectively enable drug addiction
In mice, opioids and methamphetamine (but not natural rewards) trigger calcium influx through the mitochondrial calcium uniporter in dopamine-releasing nerve terminals, fueling the rapid ATP production that sustains drug-driven dopamine surges. Blocking this mitochondrial calcium channel genetically or pharmacologically reduced drug-induced dopamine release and addictive behavior without disrupting normal reward processing, pointing to it as a possible addiction drug target.
Read →"MitoCatch" Delivers Donor Mitochondria to Specific Cell Types
A new nanobody-based delivery system precisely targets healthy donor mitochondria to damaged neurons, cardiac cells, and other specific cell types — rescuing degenerating neurons in both a human optic-nerve-atrophy cell model and mice. Still preclinical, but a concrete step toward treating primary mitochondrial diseases like TK2 deficiency.
Read →Muscle and Liver Insulin Resistance Carry Distinct Blood Protein Signatures
In 535 adults with overweight or obesity from the DiOGenes cohort, researchers split insulin resistance into its muscle and liver forms and profiled 1,128 plasma proteins. Muscle insulin resistance tracked 160 proteins dominated by inflammatory pathways, including IL-6 signalling; liver insulin resistance tracked 81 proteins centred on the complement system, with lower IGFBP-1, IGFBP-2, adiponectin and SHBG. Only 12 proteins overlapped. The authors argue this supports tissue-specific rather than one-size-fits-all interventions.
Read →Research & podcasts
Studies, reviews, news, and podcast episodes on longevity biology — evidence-graded, link-out only.